Efficacy of Artificial Salivary Substitutes in Treatment of Xerostomia: A Systematic Review

Mansour K A Assery, Mansour K A Assery

Abstract

Aim: To provide an update on artificial saliva used to maintain the health of the oral cavity of patients with severe hyposalivation.

Materials and methods: A literature search was conducted in April 2018 in three electronic databases (The Cochrane Central Register of Controlled Trials [CENTRAL], PubMed, and Embase) by combining key words and terms related to the population and intervention of the topic.

Results: The databases search resulted in 455 titles and abstracts. Of these, 21 were judged to meet inclusion criteria and full texts were read. Finally, 10 clinical trials were included for qualitative synthesis.

Conclusion: Published evidence suggests that all the artificial saliva products tested in included studies reduced symptoms of xerostomia. These products should specifically be selected according to the patients' concerns and needs. However, the included studies presented a wide range of products and suffered from high risk of bias. Therefore, long-term randomized controlled trials on effects of various products are required.

Keywords: Artificial saliva; salivary substitutes; systematic review; xerostomia.

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Flowchart for study selection process

References

    1. Tenovuo J, Lagerlöf F. Saliva. In: Thylstrup A, Fejerskov O, editors. Textbook of clinical cardiology. 2nd ed. Copenhagen, Denmark: Munksgaard; 1994.
    1. Edgar M, Dawes C, O’Mullane D. 3rd ed. London, UK: BDJ Books; 2004. Saliva and oral health.
    1. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res. 1987;66:648–53.
    1. Axelsson P. Vol. 2. Batavia, IL: Quintessence Books; 2000. Diagnosis and risk prediction of dental caries.
    1. Douglas CR. 5th ed. São Paulo, Brazil: Robe Editorial; 2002. Tratado de fisiologia aplicada à saúde.
    1. Thelin WR, Brennan MT, Lockhart PB, Singh ML, Fox PC, Papas AS, et al. The oral mucosa as a therapeutic target for xerostomia. Oral Dis. 2008;14:683–9.
    1. Gupta A, Epstein JB, Sroussi H. Hyposalivation in elderly patients. J Can Dent Assoc. 2006;72:841–6.
    1. Mouly SJ, Orler JB, Tillet Y, Coudert AC, Oberli F, Preshaw P, et al. Efficacy of a new oral lubricant solution in the management of psychotropic drug-induced xerostomia: a randomized controlled trial. J Clin Psychopharmacol. 2007;27:437–43.
    1. Sreebny LM, Valdini A, Yu A. Xerostomia. Part II: relationship to nonoral symptoms, drugs, and diseases. Oral Surg Oral Med Oral Pathol. 1989;68:419–27.
    1. Löfgren CD, Wickström C, Sonesson M, Lagunas PT, Christersson C. A systematic review of methods to diagnose oral dryness and salivary gland function. BMC Oral Health. 2012;12:29.
    1. Gil-Montoya JA, Silvestre FJ, Barrios R, Silvestre-Rangil J. Treatment of xerostomia and hyposalivation in the elderly: a systematic review. Med Oral Patol Oral Cir Bucal. 2016;21:e355–66.
    1. Hahnel S, Behr M, Handel G, Bürgers R. Saliva substitutes for the treatment of radiation-induced xerostomia—a review. Support Care Cancer. 2009;17:1331–43.
    1. Ameri A, Heydarirad G, Rezaeizadeh H, Choopani R, Ghobadi A, Gachkar L. Evaluation of efficacy of an herbal compound on dry mouth in patients with head and neck cancers: a randomized clinical trial. J Evid Based Complementary Altern Med. 2016;21:30–3.
    1. Dalodom S, Lam-Ubol A, Jeanmaneechotechai S, Takamfoo L, Intachai W, Duangchada K, et al. Influence of oral moisturizing jelly as a saliva substitute for the relief of xerostomia in elderly patients with hypertension and diabetes mellitus. Geriatr Nurs. 2016;37:101–9.
    1. Femiano F, Rullo R, di Spirito F, Lanza A, Festa VM, Cirillo N. A comparison of salivary substitutes versus a natural sialagogue (citric acid) in patients complaining of dry mouth as an adverse drug reaction: a clinical, randomized controlled study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:e15–20.
    1. Montaldo L, Montaldo P, Papa A, Caramico N, Toro G. Effects of saliva substitutes on oral status in patients with type 2 diabetes. Diabet Med. 2010;27:1280–3.
    1. Skrinjar I, Vucicevic Boras V, Bakale I, Andabak Rogulj A, Brailo V, Vidovic Juras D, et al. Comparison between three different saliva substitutes in patients with hyposalivation. Clin Oral Investig. 2015;19:753–7.
    1. Sugiura Y, Soga Y, Yamabe K, Tsutani S, Tanimoto I, Maeda H, et al. Total bacterial counts on oral mucosa after using a commercial saliva substitute in patients undergoing hematopoietic cell transplantation. Support Care Cancer. 2010;18:395–8.
    1. Heydarirad G, Rezaeizadeh H, Choopani R, Mosavat SH, Ameri A. Efficacy of a traditional Persian medicine preparation for radiation-induced xerostomia: a randomized, open-label, active-controlled trial. J Integr Med. 2017;15:201–8.
    1. Vadcharavivad S, Boonroung T. Effects of two carboxymethylcellulose-containing saliva substitutes on post-radiation xerostomia in head and neck cancer patients related to quality of life. Asian Biomed. 2013;7:93–202.
    1. Gookizadeh A, Emami H, Najafizadeh N, Roayaei M. Clinical evaluation of BIOXTRA in relieving signs and symptoms of dry mouth after head and neck radiotherapy of cancer patients at Seyed-Al-Shohada Hospital, Isfahan, Iran. Adv Biomed Res. 2012;1:72.
    1. Donath F, Tonner F, Chavda R, Gatignol JP, Bouyrie J. Randomized trial of the efficacy and safety of a new oral spray for drug-induced xerostomia. Clin Exp Dent Res. 2016;2:112–20.
    1. Salom M, Hachulla E, Bertolus C, Deschaumes C, Simoneau G, Mouly S. Efficacy and safety of a new oral saliva equivalent in the management of xerostomia: a national, multicenter, randomized study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119:301–9.
    1. Milleman JL, Milleman KR, Santos SL, Proskin HM, Battershell KK, DiMarino JC. Subjective assessment of Enamelon® preventive treatment gel in a self-reported dry-mouth population. Compend Contin Educ Dent. 2016;37:e5–8.
    1. Saraswathy B, Ganapathy D. Salivary substitutes in prosthodontics. Int J Recent Adv Multidisciplinary Res. 2016;3:1350–2.
    1. Dost F, Farah CS. Stimulating the discussion on saliva substitutes: a clinical perspective. Aust Dent J. 2013;58:11–7.
    1. Mills EJ, Chan AW, Wu P, Vail A, Guyatt GH, Altman DG. Design, analysis, and presentation of crossover trials. Trials. 2009;10:27.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren